The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
Babitt, J. L., & Lin, H. Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111078 · Cited by 1,041
Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
Levin, A., Thompson, C. R., Ethier, J., Carlisle, E. J. F., Tobe, S., Mendelssohn, D., Burgess, E., Jindal, K., Barrett, B., Singer, J., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70118-6 · Cited by 841
Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117383 · Cited by 833
Eschbach, J. W., Abdulhadi, M. H., Browne, J. K., Delano, B. G., Downing, M. R., Egrie, J. C., Evans, R. W., Friedman, E. A., Graber, S. E., Haley, N. R., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-12-992 · Cited by 795
Locatelli, F. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1032 · Cited by 785
Macdougall, I. C., Bircher, A. J., Eckardt, K.-U., Obrador, G. T., Pollock, C. A., Stenvinkel, P., Swinkels, D. W., Wanner, C., Weiss, G., Chertow, G. M., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.10.002 · Cited by 482
Locatelli, F., Bárány, P., Covic, A., De Francisco, A., Del Vecchio, L., Goldsmith, D., Hörl, W., London, G., Vanholder, R., Van Biesen, W., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft033 · Cited by 471
Hsu, C.-Y., McCulloch, C. E., & Curhan, G. C. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132504 · Cited by 453
The Safety of Intravenous Iron Preparations
Avni, T., Bieber, A., Grossman, A., Green, H., Leibovici, L., & Gafter-Gvili, A. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.007 · Cited by 441
Self-citationA randomized controlled study of iron supplementation in patients treated with erythropoietin
Macdougall, I. C., Tucker, B., Thompson, J., Tomson, C. R. V., Baker, L. R. I., & Raine, A. E. G. (1996) · Kidney International · doi:10.1038/ki.1996.487 · Cited by 417
Regidor, D. L., Kopple, J. D., Kovesdy, C. P., Kilpatrick, R. D., McAllister, C. J., Aronovitz, J., Greenland, S., & Kalantar-Zadeh, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090997 · Cited by 408
Renal handling of calcium and phosphate during mineralocorticoid “escape” in man
Rastegar, A., Agus, Z., Connor, T. B., & Goldberg, M. (1972) · Kidney International · doi:10.1038/ki.1972.107 · Cited by 397
Fishbane, S., Frei, G. L., & Maesaka, J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90151-5 · Cited by 377
Macdougall, I. C., Bock, A. H., Carrera, F., Eckardt, K.-U., Gaillard, C., Van Wyck, D., Roubert, B., Nolen, J. G., Roger, S. D., & on behalf of the FIND-CKD Study Investigators (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu201 · Cited by 328
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD
Kliger, A. S., Foley, R. N., Goldfarb, D. S., Goldstein, S. L., Johansen, K., Singh, A., & Szczech, L. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.06.008 · Cited by 270
Ferumoxytol for Treating Iron Deficiency Anemia in CKD
Spinowitz, B. S., Kausz, A. T., Baptista, J., Noble, S. D., Sothinathan, R., Bernardo, M. V., Brenner, L., & Pereira, B. J. G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101156 · Cited by 262
Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease
Agarwal, R., Vasavada, N., Sachs, N. G., & Chase, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00648.x · Cited by 261
Van Wyck, D. B., Roppolo, M., Martinez, C. O., Mazey, R. M., & Mcmurray, S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00758.x · Cited by 226
Comparative risk of anaphylactic reactions associated With intravenous iron products
Wang, C., Graham, D. J., Kane, R. C., Xie, D., Wernecke, M., Levenson, M., MaCurdy, T. E., Houstoun, M., Ryan, Q., Wong, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.15572 · Cited by 219
Iron status in patients receiving erythropoietin for dialysis-associated anemia
Van Wyck, D. B., Stivelman, J. C., Ruiz, J., Kirlin, L. F., Katz, M. A., & Ogden, D. A. (1989) · Kidney International · doi:10.1038/ki.1989.43 · Cited by 211
Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury
Zager, R. A., Johnson, A. C. M., Hanson, S. Y., & Wasse, H. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33917 · Cited by 209
A randomized trial of intravenous and oral iron in chronic kidney disease
Agarwal, R., Kusek, J. W., & Pappas, M. K. (2015) · Kidney International · doi:10.1038/ki.2015.163 · Cited by 200
Ferumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis Patients
Provenzano, R., Schiller, B., Rao, M., Coyne, D., Brenner, L., & Pereira, B. J. G. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02840608 · Cited by 187
Macdougall, I. C., Hutton, R. D., Cavill, I., Coles, G. A., & Williams, J. D. (1989) · BMJ · doi:10.1136/bmj.299.6692.157 · Cited by 186
Bailie, G. R., Larkina, M., Goodkin, D. A., Li, Y., Pisoni, R. L., Bieber, B., Mason, N., Tong, L., Locatelli, F., Marshall, M. R., et al. (2015) · Kidney International · doi:10.1038/ki.2014.275 · Cited by 186
Qunibi, W. Y., Martinez, C., Smith, M., Benjamin, J., Mangione, A., & Roger, S. D. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq613 · Cited by 184
Silverberg, D. S., Iaina, A., Peer, G., Kaplan, E., Levi, B. A., Frank, N., Steinbruch, S., & Blum, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90546-6 · Cited by 173
Parenteral versus oral iron therapy for adults and children with chronic kidney disease
Albaramki, J., Hodson, E. M., Craig, J. C., & Webster, A. C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007857.pub2 · Cited by 168
Rozen-Zvi, B., Gafter-Gvili, A., Paul, M., Leibovici, L., Shpilberg, O., & Gafter, U. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.05.033 · Cited by 163
Self-citationPisani, A., Riccio, E., Sabbatini, M., Andreucci, M., Del Rio, A., & Visciano, B. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu357 · Cited by 162
Icardi, A., Paoletti, E., De Nicola, L., Mazzaferro, S., Russo, R., & Cozzolino, M. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft021 · Cited by 158
Clinical Aspects of Iron Use in the Anemia of Kidney Disease
Hörl, W. H. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080856 · Cited by 154
Wyck, D. B. V., Cavallo, G., Spinowitz, B., Adhikarla, R., Gagnon, S., Charytan, C., & Levin, N. W. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8276 · Cited by 143
Charytan, C., Qunibi, W. Y., & Bailie, G. R. (2005) · Nephron Clinical Practice · doi:10.1159/000085049 · Cited by 129
A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease
Agarwal, R., Rizkala, A. R., Bastani, B., Kaskas, M. O., Leehey, D. J., & Besarab, A. (2006) · American Journal of Nephrology · doi:10.1159/000096174 · Cited by 127
Correction of Uremic Iron Deficiency Anemia in Hemodialyzed Patients: A Prospective Study
Fudin, R., Jaichenko, J., Shostak, A., Bennett, M., & Gotloib, L. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000045053 · Cited by 109
Kooistra, M. P., Niemantsverdriet, E. C., van Es, A., Mol-Beermann, N. M., Struyvenberg, A., & Marx, J. J. M. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.1.82 · Cited by 102
Kalra, P. A., Bhandari, S., Saxena, S., Agarwal, D., Wirtz, G., Kletzmayr, J., Thomsen, L. L., & Coyne, D. W. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv293 · Cited by 102
Acute Injury with Intravenous Iron and Concerns Regarding Long-Term Safety
Bishu, K. G., & Agarwal, R. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01420406 · Cited by 99
Parenteral iron therapy exacerbates experimental sepsis Rapid Communication
Zager, R. A., Johnson, A. C. M., & Hanson, S. Y. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00742.x · Cited by 91
Keynote Lecture: R-HuEPO hyporesponsiveness--who and why?
Drüeke, T. B. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp2.62 · Cited by 90
Sunder–Plassmann, G., & Hörl, W. H. (1997) · PubMed · Cited by 89
Parenteral versus oral iron therapy for adults and children with chronic kidney disease
Webster, A. C., & Hodson, E. M. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01660.x · Cited by 74
Hsu, C. C.-C., Bray, M. S., Kao, W. H. L., Pankow, J. S., Boerwinkle, E., & Coresh, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050468 · Cited by 70
Iron therapy in the pediatric hemodialysis population
Brugnara, C., Dahl, N. V., Watkins, S. L., Warady, B. A., Kausz, A., Lerner, G. R., Brewer, E. D., & Chadha, V. (2004) · Pediatric Nephrology · doi:10.1007/s00467-004-1457-5 · Cited by 63
Susantitaphong, P., Alqahtani, F., & Jaber, B. L. (2014) · American Journal of Nephrology · doi:10.1159/000358336 · Cited by 62
Use of intravenous iron supplementation in chronic kidney disease: an update.
Macdougall, I. C., & Geisser, P. (2013) · Iranian Journal of Kidney Diseases · Cited by 57
Nagaraju, S. P., Cohn, A., Akbari, A., Davis, J. L., & Zimmerman, D. L. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-64 · Cited by 55
Walters, B. A. J., & Wyck, D. B. V. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh811 · Cited by 51
Zager, R. A. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01410406 · Cited by 50
Iron Management in Nondialysis-Dependent CKD
Fishbane, S. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.03.007 · Cited by 43
Intravenous Iron and the Risk of Infection in End‐Stage Renal Disease Patients
Perazella, M. A., Brewster, U. C., & Perazella, M. A. (2004) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2004.17115.x · Cited by 35
Iron Supplementation in Renal Anemia
Fishbane, S. N. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.05.009 · Cited by 33
Short‐term benefits and risks of intravenous iron: a systematic review and meta‐analysis
Notebaert, É., Chauny, J., Albert, M., Fortier, S., Leblanc, N., & Williamson, D. R. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01415.x · Cited by 29
Rottembourg, J. B., & Rostoker, G. (2015) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2015.04.009 · Cited by 25
Role of Oral Iron in the Management of Long-Term Hemodialysis Patients
Lenga, I., Lok, C., Marticorena, R. M., Hunter, J., Dacouris, N., & Goldstein, M. B. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00420107 · Cited by 24
An economic evaluation of intravenous versus oral iron supplementation in people on haemodialysis
Wong, G., Howard, K., Hodson, E., Irving, M. J., & Craig, J. C. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs487 · Cited by 19
Toblli, J. E., & Gennaro, F. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125528 · Cited by 18
Tsuchida, A., Paudyal, B., Paudyal, P., ISHII, Y., Hiromura, K., Nojima, Y., & Komai, M. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.122 · Cited by 13
[Iron supplementation during erythropoietin therapy in patients on hemodialysis].
Švára, F., Sulková, S., Kvasnička, J., & Polakovič, V. (1996) · PubMed · Cited by 9
Cited by
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
Lu, M., Cohen, M. H., Rieves, D., & Pazdur, R. (2010) · American Journal of Hematology · doi:10.1002/ajh.21656 · Cited by 443
The Safety of Intravenous Iron Preparations
Avni, T., Bieber, A., Grossman, A., Green, H., Leibovici, L., & Gafter-Gvili, A. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.007 · Cited by 441
Self-citationKDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease
Woo, K. T., & Chan, C. M. (2011) · Kidney International · doi:10.1038/ki.2011.202 · Cited by 412
Richards, T., Baikady, R. R., Clevenger, B., Butcher, A., Abeysiri, S., Chau, M., Macdougall, I. C., Murphy, G., Swinson, R., Collier, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31539-7 · Cited by 346
Iron deficiency anaemia: pathophysiology, assessment, practical management
Kumar, A., Sharma, E., Marley, A., Samaan, M. A., & Brookes, M. J. (2022) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000759 · Cited by 344
Metadata
- Authors
- Shepshelovich, D., Rozen-Zvi, B., Avni, T., Gafter, U., & Gafter-Gvili, A.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 68
- Issue
- 5
- Pages
- 677-690
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W1964685535
- Cited by
- 322
- References
- 64
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.